stars 1 stars 2 stars 3

UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.

UNITY Biotechnology Questions

The UNITY Biotechnology annual revenue was $1 million in 2026.

Anirvan Ghosh is the CEO of UNITY Biotechnology.

15 people are employed at UNITY Biotechnology.

UNITY Biotechnology is based in South San Francisco, California.

The NAICS codes for UNITY Biotechnology are [541, 54171, 541711, 541712, 54, 5417].

The SIC codes for UNITY Biotechnology are [87, 873].

Top UNITY Biotechnology Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users